Processing. Please wait...
Set a start page
|
Ad to favorites
Home Page
Registration
Site search:
User panel
Login :
Password :
Registration
Lost password?
Health Conditions
Cancer
Hepatitis
Diabetes
Heart Disease
Arthritis
Obesity
Insomnia
Crohn's Disease
Free Health Offers
News Archive
August 2010 (34)
July 2010 (15)
June 2010 (6)
May 2010 (15)
April 2010 (55)
March 2010 (10)
February 2010 (10)
January 2010 (89)
December 2009 (110)
November 2009 (95)
October 2009 (205)
September 2009 (260)
August 2009 (335)
July 2009 (303)
June 2009 (228)
May 2009 (340)
April 2009 (345)
March 2009 (111)
December 2008 (5)
October 2008 (1)
June 2008 (47)
May 2008 (35)
April 2008 (89)
March 2008 (75)
February 2008 (47)
January 2008 (85)
December 2007 (65)
November 2007 (95)
October 2007 (132)
September 2007 (42)
December 1969 (3)
Our Polling
My main cholesterol strategy is:
Exercise
Heart-healthy diet
Herbs & Supplements
Medication
Surface Logix Achieves Objectives In Hypertension Clinical Trial
Health News
Surface Logix announced positive results in Phase 2a clinical trial of SLx-2101 in hypertension.
Details
0
1
2
3
4
5
Views: 60 Autor:
Admin
9 January 2008
Comments (0)
Survey Tool Helps Consumers Rate Experiences With Their Doctors
Health News
WellPoint is helping address an unmet need for peer-to-peer interaction among health care consumers.
Details
0
1
2
3
4
5
Views: 88 Autor:
Admin
9 January 2008
Comments (0)
Study Indicates Decreasing Prescription Copayments Results In Increased Adherence For Patients Wi...
Health News
Removing economic barriers to treatment for chronic conditions encourages patients to remain on recommended therapies.
Details
0
1
2
3
4
5
Views: 42 Autor:
Admin
9 January 2008
Comments (0)
Trial To Measure Impact Of VIA-2291 To Reduce Vascular Inflammation
Health News
VIA Pharmaceuticals has enrolled the first patient in its Phase 2 clinical trial that utilizes FDG-PET to measure VIA-2291's ability to reduce vascular inflammation in treated patients.
Details
0
1
2
3
4
5
Views: 55 Autor:
Admin
9 January 2008
Comments (0)
Maxygen Announces Positive Progress In Phase Clinical Trial Of Novel PEG-GCSF
Health News
Maxygen announced positive progress in its Phase IIa trial of MAXY-G34 for the treatment of chemotherapy-induced neutropenia.
Details
0
1
2
3
4
5
Views: 38 Autor:
Admin
9 January 2008
Comments (0)
Calendar
«
January 2008
»
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Advertising
Home Page
|
Registration
|
Disclaimer
Copyright © 2007 My Health Portal. All Rights Reserved.
